H. Miura et Dd. Gutterman, HUMAN CORONARY ARTERIOLAR DILATION TO ARACHIDONIC-ACID DEPENDS ON CYTOCHROME-P-450 MONOOXYGENASE AND CA2-ACTIVATED K+ CHANNELS(), Circulation research, 83(5), 1998, pp. 501-507
Citations number
40
Categorie Soggetti
Hematology,"Peripheal Vascular Diseas","Cardiac & Cardiovascular System
Endothelium-dependent hyperpolarization of vascular smooth muscle cell
s (VSMCs) plays a crucial role in regulating vascular tone, especially
in resistance vessels. It has been proposed that metabolites of arach
idonic acid (AA), formed by cytochrome P-450 monooxygenase (P450), are
endothelium-derived hyperpolarizing factors (EDHFs). These metabolite
s have been reported to mediate dilation to endogenous vasoactive comp
ounds, such as bradykinin and acetylcholine. However, it is not known
whether these metabolites of AA contribute to dilation of human resist
ance vessels. This is important since it has been proposed that EDHF s
erves as a compensatory mechanism to maintain dilation in disease stat
es. Therefore, we studied the effect of AA on vessel diameter and VSMC
membrane potential in isolated human coronary microvessels. Arteriole
s (81+/-5 mu m, n=70) were dissected from right atrial appendages at t
he time of cardiac surgery and cannulated at a distending pressure of
60 mmHg and zero flow. Changes in internal diameter were recorded with
videomicroscopy. Some vessels were impaled with glass microelectrodes
to measure membrane potential of VSMCs while internal diameters were
simultaneously recorded. After constriction (47+/-2%) with endothelin-
1, AA (10(-10) to 10(-5) mol/L) induced substantial dilation of human
coronary microvessels, which was abolished by removal of the endotheli
um. Treatment with 17-octadecynoic acid (17-ODYA, 10(-5) mol/L; a P450
inhibitor) attenuated maximal dilation to AA (49+/-9% versus 91+/-4%
[control]; P<0.05 versus control), whereas indomethacin (INDO, 10(-5)
mol/L; a cyclooxygenase inhibitor) and N-omega-nitro-L-arginine methyl
ester (L-NAME, 10(-4) mol/L; a NO synthase inhibitor) were without ef
fect. Both I7-ODYA and miconazole (10(-5) mol/L, a chemically distinct
P450 inhibitor) further reduced the dilation to AA in the presence of
INDO. The presence of 40 mmol/L KCl or charybdotoxin (10(-8) mol/L, a
blocker of large-conductance Ca2+-activated K+ channels) impaired dil
ation to AA (19+/-9% [KCl] versus 76+/-5% [control] and 47+/-6% [chary
bdotoxin] versus 91+/-3% [control]; P<0.05 for both). After depolariza
tion with endothelin-1 (-26+/-1 mV from -48+/-3 mV [before endothelin]
), AA (10-5 mol/L) in the presence of INDO and L-NAME induced hyperpol
arization of VSMCs (-57+/-5 mV). In the presence of 17-ODYA together w
ith INDO and L-NAME, endothelin produced similar depolarization (-26+/
-2 mV from -48+/-3 mV), but hyperpolarization to AA was reduced (-33+/
-2 mV; P<0.05 versus absence of 17-ODYA). AA metabolites formed primar
ily by P450 produce potent endothelium-dependent dilation of human cor
onary arterioles via opening of Ca2+-activated K+ channels and hyperpo
larization of VSMCs. These findings support an important role for P450
metabolites in the regulation of human coronary arteriolar tone.